As of Jun 20
| -0.0012 / -5.66%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 0.60, with a high estimate of 0.60 and a low estimate of 0.60. The median estimate represents a +2,900.00% increase from the last price of 0.02.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.